Starling Oncology, Inc. 為一家腫瘤學公司,於美國提供各類腫瘤學服務。公司總部位於加州喜瑞都。
財務指標
營業收入
2026-06-30
$161.28M
2026-03-31
$147.44M
2025-12-31
$141.95M
2025-09-30
$136.56M
營業支出
2026-06-30
$31.78M
2026-03-31
$29.82M
2025-12-31
$29.67M
2025-09-30
$26.97M
淨利潤
2026-06-30
-$9.78M
2026-03-31
-$2.49M
2025-12-31
-$7.5M
2025-09-30
-$16.5M
淨利潤率
2026-06-30
-6.06%
2026-03-31
-1.69%
2025-12-31
-5.28%
2025-09-30
-12.08%
每股收益
2026-06-30
$-0.08
2026-03-31
$-0.02
2025-12-31
$-0.06
2025-09-30
$-0.14
息稅折舊攤銷前利潤
2026-06-30
-$6.09M
2026-03-31
$1.05M
2025-12-31
-$3.96M
2025-09-30
-$12.86M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$161.28M
$147.44M
$141.95M
$136.56M
營業支出
$31.78M
$29.82M
$29.67M
$26.97M
淨利潤
-$9.78M
-$2.49M
-$7.5M
-$16.5M
淨利潤率
-6.06%
-1.69%
-5.28%
-12.08%
每股收益
$-0.08
$-0.02
$-0.06
$-0.14
息稅折舊攤銷前利潤
-$6.09M
$1.05M
-$3.96M
-$12.86M
有效稅率
--
--
--
--
常見問題
STLN is a publicly traded equity security that represents fractional ownership in its underlying company. The ticker STLN is used to identify the stock on U.S. exchanges. To understand what STLN specifically represents, investors should review the company’s official profile, SEC filings, and the latest data shown on this page. STLN shares can be bought or sold through a brokerage account during regular market hours, and its price moves based on supply and demand.
STLN’s recent performance reflects its closing price changes over the latest trading sessions. Because stock prices fluctuate daily, the most accurate and current performance figures for STLN are available on this page. Investors often compare recent returns with the broader market or sector to gauge relative strength, but short-term moves can be volatile. Reviewing the displayed price chart and percentage changes provides the latest picture of STLN’s recent trading activity.
Evaluating STLN’s valuation involves reviewing metrics such as the price-to-earnings ratio, price-to-sales, price-to-book, and enterprise value. These measures help compare STLN’s market price with its earnings, revenue, or assets. Investors should also consider growth prospects, industry norms, and debt levels. Because valuation multiples change with price and financial updates, use the latest metrics displayed for STLN on this page rather than relying on outdated figures.
STLN can be traded through a licensed U.S. brokerage, either via an online platform or a full-service broker. Orders are typically executed on the exchange where STLN is listed. Trading occurs during regular market hours, though some brokers offer extended-hours sessions. To trade STLN, you need a funded brokerage account and must place a buy or sell order. Availability may depend on your broker and any restrictions on the stock.
Whether STLN pays dividends depends on its current corporate policy. Some companies distribute part of their profits as regular cash dividends, while others retain earnings for growth or reinvestment. Dividend information for STLN, including payment dates and amounts, is typically announced by the company and can be found in its investor relations materials or on this page if available. Always verify the latest dividend status before making any assumptions.
Key risks for STLN include market volatility, sector-specific challenges, and company-specific factors such as competition, debt, or operational setbacks. Broader economic conditions, interest rate changes, or regulatory shifts can also affect STLN’s business and stock price. Additionally, liquidity risk may apply if trading volume is low. Reviewing STLN’s SEC filings and the risk factors section of its annual report provides a detailed, company-specific risk assessment.